Value of Rox Index to Predict Intubation and Intensive Care Unit Outcome in Patients with Respiratory Failure.

IF 1.4 Q4 PHARMACOLOGY & PHARMACY Reviews on recent clinical trials Pub Date : 2022-06-06 DOI:10.2174/1574887117666220606114549
Ayshan Mammadova, Esra Eriş, Zeynep Sena Solmaz, Ayşe Taşçı Kara, Aydın Atasoy, Gül Gürsel
{"title":"Value of Rox Index to Predict Intubation and Intensive Care Unit Outcome in Patients with Respiratory Failure.","authors":"Ayshan Mammadova, Esra Eriş, Zeynep Sena Solmaz, Ayşe Taşçı Kara, Aydın Atasoy, Gül Gürsel","doi":"10.2174/1574887117666220606114549","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recent literature suggests that the respiratory rate oxygenation (ROX) index may be a useful parameter in predicting intubation indication in hypoxemic patients.</p><p><strong>Objective: </strong>In this study, we evaluated the accuracy of the ROX index in predicting intubation, length of stay in the ICU, and mortality in ICU patients with hypoxemic respiratory failure with and without hypercapnia.</p><p><strong>Methods: </strong>Single-centre retrospective cohort study of 290 patients, with a preliminary diagnosis of respiratory failure, who were treated with low flow oxygen systems. Demographics, medical history, clinical, laboratory, treatment, and prognostic data were obtained from the electronic records of the hospital. The ROX index was calculated at the time of ICU admission.</p><p><strong>Results: </strong>Thirty-seven percent of non-hypercapnic and 69% of hypercapnic patients were intubated (p:0.005). In hypercapnic patients, ROX: 6.9 had highest sensitivity (81%) and specificity (65%) values for intubation (p:0.005). In non-hypercapnic patients, ROX: 6.2 had the highest sensitivity (81%) and specificity (40%) values. While 11% of hypercapnic patients and 30% of non-hypercapnic patients were died (p:0.05), 22% of hypercapnic patients and 33% of non-hypercapnic patients stayed in the ICU longer than 14 days (p:0.044). The highest sensitivity and specificity values were found for mortality in hypercapnic patients; for ROX value of 5.94 (sensitivity:86%, specificity:61%) and for ICU stay longer than 14 days; for ROX value of 7.4 (sensitivity:71%, specificity:68%).</p><p><strong>Conclusion: </strong>Results of our study suggest that ROX index calculated during ICU admission can be helpful in predicting intubation indication and length of ICU stay in patients with respiratory failure and hypercapnia may influence the cutoff values.</p>","PeriodicalId":21174,"journal":{"name":"Reviews on recent clinical trials","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on recent clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574887117666220606114549","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Recent literature suggests that the respiratory rate oxygenation (ROX) index may be a useful parameter in predicting intubation indication in hypoxemic patients.

Objective: In this study, we evaluated the accuracy of the ROX index in predicting intubation, length of stay in the ICU, and mortality in ICU patients with hypoxemic respiratory failure with and without hypercapnia.

Methods: Single-centre retrospective cohort study of 290 patients, with a preliminary diagnosis of respiratory failure, who were treated with low flow oxygen systems. Demographics, medical history, clinical, laboratory, treatment, and prognostic data were obtained from the electronic records of the hospital. The ROX index was calculated at the time of ICU admission.

Results: Thirty-seven percent of non-hypercapnic and 69% of hypercapnic patients were intubated (p:0.005). In hypercapnic patients, ROX: 6.9 had highest sensitivity (81%) and specificity (65%) values for intubation (p:0.005). In non-hypercapnic patients, ROX: 6.2 had the highest sensitivity (81%) and specificity (40%) values. While 11% of hypercapnic patients and 30% of non-hypercapnic patients were died (p:0.05), 22% of hypercapnic patients and 33% of non-hypercapnic patients stayed in the ICU longer than 14 days (p:0.044). The highest sensitivity and specificity values were found for mortality in hypercapnic patients; for ROX value of 5.94 (sensitivity:86%, specificity:61%) and for ICU stay longer than 14 days; for ROX value of 7.4 (sensitivity:71%, specificity:68%).

Conclusion: Results of our study suggest that ROX index calculated during ICU admission can be helpful in predicting intubation indication and length of ICU stay in patients with respiratory failure and hypercapnia may influence the cutoff values.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Rox指数预测呼吸衰竭患者插管和重症监护室结果的价值。
背景最近的文献表明,呼吸速率氧合(ROX)指数可能是预测低氧血症患者插管指征的有用参数。目的在本研究中,我们评估了ROX指数在预测伴有和不伴有高碳酸血症的低氧性呼吸衰竭ICU患者的插管、ICU住院时间和死亡率方面的准确性。方法对290名初步诊断为呼吸衰竭并接受低流量氧气系统治疗的患者进行单中心回顾性队列研究。从医院的电子记录中获得人口统计学、病史、临床、实验室、治疗和预后数据。ROX指数在入住ICU时进行计算。结果约有7%的非高碳酸血症患者和69%的高碳酸血症病人插管(p:0.005)。在高碳酸血症的患者中,ROX:6.9对插管的敏感性(81%)和特异性(65%)最高(p:0.005)。在非高碳酸症的病人中,ROX:6.2的敏感性(81%)和特异度(40%)最高。11%的高碳酸血症和30%的非高碳酸血症患者死亡(p:0.05),22%的高碳酸症患者和33%的非高二氧化碳血症患者在ICU停留时间超过14天(p:0.044);ROX值为5.94(敏感性:86%,特异性:61%),ICU住院时间超过14天;ROX值为7.4(敏感性:71%,特异性:68%)。结论我们的研究结果表明,在ICU入院期间计算的ROX指数有助于预测呼吸衰竭和高碳酸血症患者的插管指征和ICU住院时间可能会影响临界值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Reviews on recent clinical trials
Reviews on recent clinical trials PHARMACOLOGY & PHARMACY-
CiteScore
3.10
自引率
5.30%
发文量
44
期刊介绍: Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
期刊最新文献
Impact of Upright Position during the First Stage of Labour on Maternal Outcomes: A Randomized Controlled Trial. Study on Rapid, Quantitative, and Simultaneous Detection of Drug Residues and Immunoassay in Chickens. Impact of a Symbiotic Mixture on Moderate-to-severe Diverticular Disease of the Colon. Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report. Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1